The Treatment of Depression With Botulinum Type A Toxin
Status:
Completed
Trial end date:
2013-06-01
Target enrollment:
Participant gender:
Summary
A 24-week Randomized, Double-blind study treating people who suffer from depression who also
have moderate to severe frown lines in forehead region with Botox injections. Subjects
participating will have their photos taken and complete a questionnaire regarding their
depression. They will see a psychiatrist at every visit who will assess their depression.
Phase:
Phase 2
Details
Lead Sponsor:
Seton Healthcare Family
Treatments:
abobotulinumtoxinA Botulinum Toxins Botulinum Toxins, Type A incobotulinumtoxinA onabotulinumtoxinA Pharmaceutical Solutions